Intrinsic subtype and therapeutic response among early stage HER2-positive breast tumors from the North Central Cancer Treatment Group (Alliance) N9831 trial
- Citation:
- Cancer Res vol 76 (4 Suppl) P3-07-04
- Meeting Instance:
- SABCS 2015
- Year:
- 2016
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2328
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Edith A. Perez Karla V. Ballman Afshin Mashadi-Hossein Kathleen S. Tenner Jennifer M. Kachergus Nadine Norton Brian M. Necela Jennifer M. Carr Sean Ferree Charles M. Perou Maggie Chon U. Cheang E. Aubrey Thompson
- Networks:
- LAPS-MN026, LAPS-NC007, PR028
- Study
- NCCTG-N9831
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: